1. Corporate Officers - L
2. Lapidus Stanley

Insider Trading History of Lapidus Stanley

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Lapidus Stanley since 2017. This trader's CIK number is 1678195. At the time of last reporting, Lapidus Stanley was the Director of Lucid Diagnostics Inc.. (stock ticker symbol LUCD). Also see all insider trading activities at Lucid Diagnostics Inc..

Note that in the past Lapidus Stanley also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Lucid Diagnostics Inc. (LUCD) by Lapidus Stanley

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2023	LUCD	0	$0	33,864	$49,107	0	$0
2022	LUCD	0	$0	33,864	$57,670	0	$0

Yearly summary of insider trading at T2 Biosystems, Inc. (TTOO) by Lapidus Stanley

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2019	TTOO	0	$0	9,000	$12,960	9,000	$0
2018	TTOO	0	$0	12,048	$85,212	45,058	$31,387
2017	TTOO	0	$0	0	$0	20,000	$23,200

Insider trading activities at 2 companies by Lapidus Stanley:

1. Lucid Diagnostics Inc. (LUCD)

2. T2 Biosystems, Inc. (TTOO)

Table 1. Insider trading of Lucid Diagnostics Inc. (LUCD) by Lapidus Stanley

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2023-09-25	LUCD	Sale	200	1.43	286
2023-09-26	LUCD	Sale	29,747	1.45	43,162
2023-09-21	LUCD	Sale	100	1.44	144
2023-09-20	LUCD	Sale	3,817	1.45	5,515
2022-09-20	LUCD	Sale	33,864	1.70	57,670

Table 2. Insider trading of T2 Biosystems, Inc. (TTOO) by Lapidus Stanley

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2019-06-11	TTOO	Sale	9,000	1.44	12,960
2019-06-08	TTOO	Option Ex	9,000	.00	0
2018-11-06	TTOO	Option Ex	27,058	1.16	31,387
2018-11-06	TTOO	Sale	6,048	5.29	31,993
2018-06-02	TTOO	Option Ex	18,000	.00	0
2018-06-05	TTOO	Sale	6,000	8.87	53,219
2017-06-06	TTOO	Option Ex	20,000	1.16	23,200

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lapidus Stanley (Director of Lucid Diagnostics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month